Theralase Technologies Inc. V.TLT

266% increase...

[wildbird1]

As described in this link...
Five reasons why bowel cancer is becoming more common in under 50s

-There has been a 266% increase in Bowel Cancer rates among adolescents and young adults over the past three decades (the above can be said of almost all cancer).

- With all the new cancer treatments that are available, people with cancer are living longer...but on the other hands the number of people getting cancer is increasing at a faster rate(strange paradox),and patients are getting cancer at a much younger age than before.

It is the FDA job to address this new problem before it become apocalyptic.

OnceTLT-Ruvidar has been approved by the FDA, TLT will push forward with Metformin+Rutherrin to be part the solution for this FDA new big problem, as Metformin+Rutherrin has the potential to easily treat any cancer anywhere in the body.

All the above is one more reason why the FDA has no choice but to give TLT-Ruvidar pre-BTD and BTD approval, before this new problem become apocaliptic.

You have to admit that the future combination of Metformin+Rutherrin is mind-boggling.

[Tarbaby]

So far they have only announced that cancer cell lines in a petrie dish have been destroyed by the Rutherrin/Metformin/xray combo. THATS A GREAT START but for major credibility they need to show that same response in live animal studies independantly verified. They should delay their pp until that is done perhaps a month when the share price is much higher..like $1.00...imo.

[Longholder99]

I'm sure a live animal trial will only take a month to set up, complete, and report on.  Piece of cake.  

[DeathXray33]

Slick-Con-007 has a market cap of 2.53 billion... ------------------------------------------------------------ "Pharma stock Theralase paves way for in-home cancer treatment" ----------- "Pharma stock Theralase Technologies (TSXV:TLT) has found pre-clinical evidence that its lead drug candidate, Rutherrin, is activated by Metformin, a common diabetes drug, without the use of light

[Mikee3003]

"OnceTLT-Ruvidar has been approved by the FDA, TLT will push forward with Metformin+Rutherrin to be part the solution for this FDA new big problem, as Metformin+Rutherrin has the potential to easily treat any cancer anywhere in the body." "All the above is one more reason why the FDA has no choice but to give TLT-Ruvidar pre-BTD and BTD approval, before this new problem become

[N0taP00p]

@Mikee3003:  I think the Kool-Aid is almost as potent as Ruvidar. 

[Mikee3003]

Apparently a foreign group is now working on a combo Kool Aid + Metformin treatment. To date there have been incredible petrie dish results for the treatment of pumpastockatitus. 

[DeathXray33]

"the viral inactivation mediated by TLD-1433-PDT-induced ROS is effective against different families of viruses, not only enveloped but also non-enveloped, via lipid peroxidation and potentially other mechanisms. Immune recognition structures appear to remain intact during this inactivation. This opens potential opportunity to generate a broad spectrum of inactivated virus(es) vaccines with

[Longholder99]

Well you know that National Council for Biotechnology Information. Shameless stock pumpers they've always been known to be.